S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ORGS Orgenesis Inc

0.5149

0.0289 (5.95%)

May 31 2024 - Closed

Delayed by 15 minutes

Form D - Notice of Exempt Offering of Securities

Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Orgenesis Charts.

Orgenesis (NASDAQ:ORGS)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Orgenesis Charts.

Orgenesis Inc News

Form 8-K - Current report
Friday 31 May 2024 (1 day ago) • Edgar (US Regulatory)

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
Friday 24 May 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 May 2024 (1 week ago) • Edgar (US Regulatory)

Orgenesis Provides Business Update for the First Quarter of 2024
Tuesday 21 May 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 20 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Wednesday 15 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form ARS - Annual Report to Security Holders
Monday 6 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Monday 6 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Monday 6 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Orgenesis Provides Year End Business Update
Monday 15 April 2024 (2 months ago) • GlobeNewswire Inc.

Germfree and Orgenesis Announce Asset Purchase and Strategic Partnership Intended to Revolutionize Cell and Gene Therapy Through Decentralized Production and Global Accessibility
Wednesday 10 April 2024 (2 months ago) • GlobeNewswire Inc.

Vered Caplan, CEO of Orgenesis, to Present at the Bioprocessing Summit Europe Conference
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

More Orgenesis Inc News Articles

Klepierre SA 2% until 12...

Vontobel Financial Produ...

NLBNPIT22678 20991231 2....

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions